Anti-Wrinkle Injections & Dermal Fillers

Anti-wrinkle injections (botulinum toxin) and hyaluronic acid dermal fillers for facial rejuvenation without surgery. Anti-wrinkle injections target forehead lines, frown lines, crow's feet, and jaw slimming. Dermal fillers restore volume to lips, cheeks, and nasolabial folds. Both treatments require an initial consultation under TGA guidelines. Results are natural-looking and gradually reversible.

Mandurah Cosmetic Clinic WA offers cosmetic injectable treatments including botulinum toxin anti-wrinkle injections and hyaluronic acid dermal fillers — two of the most commonly requested non-surgical cosmetic procedures in Australia. Anti-wrinkle injections use purified botulinum toxin, a Schedule 4 prescription medicine under Australian TGA regulations, to temporarily relax specific facial muscles responsible for dynamic wrinkles formed by repeated muscle movement. Common treatment sites include the horizontal forehead lines (frontalis), vertical frown lines between the brows (glabellar complex), lateral crow's feet around the eyes (orbicularis oculi), bunny lines on the nose bridge, and the masseter muscles for jaw slimming and facial contouring. Results typically onset within three to seven days and last approximately three to four months. Hyaluronic acid dermal fillers are injectable gels that physically restore volume, enhance contours, and smooth static lines and folds. Common applications include lip volume and definition enhancement, mid-face and cheek volumisation, softening of nasolabial (smile) lines and marionette lines, chin and jawline contouring, and non-surgical nose refinement. Hyaluronic acid is a naturally occurring glycosaminoglycan found in skin and connective tissue, and modern filler formulations are engineered with varying degrees of cross-linking to deliver different viscosities suited to superficial, mid-dermal, or deep volumising applications. For Mandurah and Peel Region residents in Western Australia, access to qualified cosmetic injectable practitioners locally eliminates the need to travel to Perth clinics for these widely sought non-surgical treatments. TGA regulations in Australia prohibit the public advertising of Schedule 4 prescription medicine pricing; all injectable pricing is disclosed at consultation following a clinical assessment of suitability.